Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02570711
Title Study of Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Previously Untreated Metastatic Pancreatic Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Acerta Pharma BV
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Ventura Clinical Trials Ventura California 93003 United States Details
Florida Cancer Specialists Fort Myers Florida 33916 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Oncology Hematology Care Cincinnati Ohio 45242-5665 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Tennessee Oncology Chattanooga Tennessee 37404 United States Details
Tennessee Oncology Nashville Tennessee 37205 United States Details
The Center for Cancer and Blood Disorders Fort Worth Texas 76104 United States Details
MD Anderson Cancer Center Houston Texas 77030-4000 United States Details
International Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field